commiss decis februari declar concentr compat common market function eea agreement case iv hoffmann la roch boehring mannheim notifi document number english text authent text eea relev ec commiss european commun regard treati establish european commun regard agreement european econom area articl thereof regard council regul eec decemb control concentr undertak amend act access austria finland sweden articl thereof regard commiss decis octob initi proceed case undertak concern opportun make view object rais commiss regard opinion advisori committe concentr septemb hoffmann la roch group roch notifi acquisit affili roch healthcar share corang famili group roch acquir sole control corang mean articl regul eec merger regul decis septemb commiss order continu suspens notifi concentr pursuant articl articl merger regul final decis reach case octob commiss decid initi proceed pursuant articl merger regul investig case agreement european commun govern unit state america applic competit law activ parti roch activ product distribut pharmaceut vitamin fine chemic diagnost flavour fragranc corang corang hold compani oper busi activ control boehring mannheim group bm own share depui bm manufactur distributor diagnost pharmaceut biochem depui manufactur distributor orthopaed product devic ii oper propos oper consist acquisit equiti corang roch roch assum sole control corang bm depui iii commun dimens roch corang combin aggreg worldwid turnov excess ecu million roch ecu million corang ecu million commun wide turnov excess ecu million roch ecu million corang ecu million achiev third aggreg turnov member state notifi oper commun dimens iv competit assess roch corang bm partli overlap busi activ vitro diagnost pharmaceut product inform provid parti overlap orthopaed fragranc flavour fine chemic biochem vitamin bulk quantiti vitamin bulk quantiti sold larg quantiti anim feed industri food industri cosmet industri pharmaceut industri substitut medicin vitamin compound pharmaceut product relev product market commiss occas dealt definit relev market case pharmaceut product establish number principl previou decis decis june sanofi sterl drug case iv april procordia erbamont case iv april rhône poulenc cooper case iv june la roch syntex case iv septemb ahp cynamid case iv februari glaxo wellcom case iv april behringwerk ag armour pharmaceut case iv june hoechst marion merrel dow case iv septemb upjohn pharmacia case iv decis note medicin subdivid therapeut class refer anatom therapeut classif atc recognis world health organis classif medicin group refer composit therapeut properti level atc classif medicin group term therapeut indic intend oper market definit carri analys level atc classif medicin subdivid segment basi varieti criteria demand relat criteria distinct medicin issu prescript sold counter distinct medicin refund part sick insur scheme reimburs segment partli overlap medicin issu prescript reimburs sold counter reimburs alloc medicin segment perman base decis author lead segment parti agre commiss case base market definit level atc classif level product gener serv treatment purpos interchang product class parti identifi product market affect concentr cephalosporin anti coagul inject antiacid antiflatul lax immunostimul steroid vitamin compound hepat protector lipotrop pharmaceut industri full assess competit situat requir examin product market advanc stage develop extrem larg sum monei invest potenti product enter competit product develop stage market assess refer characterist intend therapeut born mind research develop rule trade pharmaceut compani intend primarili develop compani activ substanc product hand cooper take place research field pharmaceut compani public privat research institut small biotechnolog undertak relev resourc facil clinic test carri prior market authoris manufactur pharmaceut commiss amp potenti term import exist market futur market research develop assess term import futur market relev product market natur thing defin clear cut manner case exist market market definit base exist atc class exist product replac guid primarili indic fixtur product appli relev geograph market effort european standardis pharmaceut product harmonis technic provis commun entri forc registr procedur medicin repres complet programm singl market term scientif technic requir appli medicin begin pharmaceut compani option case biotechnolog product oblig submit applic registr medicin european agenc evalu medicin product issu recommend commiss decis bind member state present medicin regist member state indic sale medicin influenc administr procedur purchas polici nation health author introduc member state countri exercis direct indirect influenc price level reimburs social secur system categori medicin reason price medicin product differ member state addit reach differ term brand pack size strategi distribut system differ lead nation market characterist market pharmaceut product defin nation market decis hitherto adopt commiss view accept parti notif market affect concentr regard nation extent futur product market consid basi research develop area nation restrict degre effect characterist fixtur market product regist research develop global consider futur market focu territori commun possibl worldwid market assess product market affect concentr competit problem parti combin market share number strong intern competitor parti overlap lead market share itali antirheumat steroid vitamin compound hepat protector lipotrop italian market bm amp lt roch amp lt bm amp lt roch amp lt number intern competitor novarti pfizer pharmacia amp upjohn itali bm share amp lt roch amp lt parti combin market share amp lt roch product benerva market share amp lt fulli substitut bm roch product compound compos vitamin major competitor bioindustria pfizer group competitor lepetit hoechst group angelini bracco guidotti menarini market volum ecu million major product market introduc decad ago except pfizer product neuraben product year doubl market share compet vigor roch bm product situat chang merger addit import note product belong class patent free reimburs italian nation health servic doctor patient freeli choos brand bm roch rais price custom easili switch compet product incent product reimburs itali fulli paid consum barrier entri low pharmaceut compani easili start product product import product sold member state consum demand increas price rise reason concentr threaten creat strengthen domin posit product market investig suggest overlap roch bm market drug treatment manag prevent acut myocardi infarct heart attack futur competit concern investig reveal problem relat market europ genentech roch product activas licens independ parti boehring ingelheim compani product facil europ depend genentech suppli raw materi finish product competit situat chang result concentr final field activ substanc research develop investig reveal signific overlap field tissu plasminogen activ product abovement heart attack medicin vitro diagnost relev product market overview concentr concern area diagnost analysi diagnost analysi procedur monitor physiolog condit subject analyt procedur differ depend design analys gener health condit subject specif ill pre birth patholog concern reaction subject substanc diagnost test perform vitro vivo vitro liter glass diagnost ivd test conduct bodi identifi measur substanc patient tissu blood urin sampl enabl physician diagnos treat monitor patient vivo method concern diagnost substanc directli human bodi method complementari applic roch bm activ field vitro diagnost larg part vitro diagnost sold form multi diagnost system hospit commerci laboratori univers laboratori institut addit signific quantiti vitro diagnost market singl product gener practition public author employ instanc sold test kit counter rapid test pregnanc diabet cholesterol test kit complementari multi test kit applic concentr roch bm concern primarili multi vitro diagnost includ dna probe site diagnost product gener form system compos measur instrument design autom oper kind test reagent instrument reagent compound liquid perform test suppli part reagent kit includ control substanc test serum verifi smooth function measur instrument calibr serv regular weekli adjust measur instrument main part multi product busi characteris seri test kit adapt system major supplier offer packag consist measur instrument seri test kit comprehens sale servic includ qualiti control develop system requir larg sum compani diagnost industri spend total turnov amp turnov achiev sale instrument reagent kit account rest explain competit diagnost market focus secur sale reagent supplier strong interest obtain long term order continu suppli reagent kit diagnost manufactur follow strategi pursuit aim trend diagnost compani market product close system design exclus reagent common featur industri deliveri contract custom conclud year instrument leas put custom dispos low cost charg condit custom purchas number reagent kit time period year instrument free charg custom instrument cost includ reagent price respect commiss investig bought instrument amortis period year diagnost industri intern calcul reagent leas contract calcul shorter amortis year custom paid instrument paid purchas directli rational accept offer custom public privat laboratori prefer budgetari reason total cost system charg run cost long term invest instrument supplier includ parti design sale method price instrument charg separ includ price reagent investig larg confirm parti view technic viewpoint reagent supplier instrument produc provid technolog correspond appli close system depend mean emploi achiev close system specif contain shape bar code appear switch reagent supplier requir invest term time effort part custom larg custom unwilling depend specif supplier close system major custom contact commiss gener parti reagent greater extent consist fact captur rate extent diagnost supplier continu sell reagent custom purchas instrument parti competitor gener high field vitro diagnost divid main segment clinic chemistri immunochemistri haematolog histolog microbiolog cultur infecti immunolog correspond level product classif produc european diagnost manufactur associ edma classif gener accept industri compil sale data individu reagent european scale commiss investig custom hand state familiar classif segment affect oper confirm classifi diagnost demand side point view addit dna probe encompass test area infecti diseas oncolog genet diseas tissu type undergo strong expans assess concentr roch bm lead major overlap field classic clinic chemistri immunochemistri diagnost signific effect field dna probe classic clinic chemistri reagent classic clinic chemistri diagnost primarili test glucos cholesterol sodium substanc found larg concentr bodi test typic run routin emerg patient doctor understand perform basic bodili function level edma classif distinguish product group classic clinic chemistri parti opinion relev distinct market definit purpos rapid test clinic chemistri cc reagent rapid test primarili manual test glucos monitor carri patient doctor reagent hand perform diagnost test instrument laboratori commiss investig confirm rapid test constitut separ product market due differ custom distribut channel competit condit question rapid test constitut product market separ product market blood test strip urin test strip left open altern market definit consid effect competit significantli imped eea substanti part area reagent parti state notif cc reagent group common characterist custom regularli bui requir test sourc suppli side major supplier offer rang instrument reagent commiss investig confirm condit competit ident reason invok parti group reagent product market strictli speak substitut demand side point view submiss parti extend market definit state immunochemistri reagent homogen immunoassai hia includ product market clinic chemistri reagent custom bui cc hia reagent sourc clinic chemistri instrument roch integra hia test major supplier offer product rang commiss investig found condit competit hia cc reagent includ product market hia reagent product characterist clinic chemistri reagent immunochemistri test requir complex detect technolog measur substanc capabl detect lower concentr expens cc reagent competit constraint supplier hia supplier cc reagent custom perform test partli clinic chemistri instrument bui requir hia reagent sourc cc reagent supplier immunochemistri instrument altern face small signific transitori price increas hia reagent compar situat relat cc reagent custom switch supplier hia activ cc abbott run test immunochemistri instrument import competit altern market share distribut hia cc reagent parti bm market share eea cc reagent hia abbott hand market share cc reagent hia reagent thirdli suppli side major clinic chemistri supplier offer rang hia test run clinic chemistri machin commiss conclud separ product market clinic chemistri reagent includ homogen immunoassai immunochemistri reagent immunochemistri involv target antibodi identifi test enzym drug hormon substanc found small concentr bodi depend condit monitor number applic distinguish regard product market parti overlap exist specif protein tumour marker thyroid function hormon anaemia relat vitamin test therapeut drug monitor rheumatoid autoimmun diseas standard control reason group immunochemistri reagent includ level edma group strong case clinic chemistri immunochemistri signific differ relat import technic differ user custom regularli bui requir test sourc suppli side major supplier offer rang instrument reagent view group relev market purpos case question left open altern market definit consid effect competit significantli imped eea substanti part area classic clinic chemistri immunochemistri instrument instrument measur instrument process test size rang small instrument high end high throughput instrument major reagent supplier provid instrument produc roch sourc instrument independ machin manufactur case bm produc instrument achiev larger part instrument sale exclus distributor hitachi machin europ instrument market bm hitachi instrument edma classif separ instrument product group notif approach broad market definit purpos present gener analyt instrument gener cover diagnost test aforement segment clinic chemistri immunochemistri instrument perform clinic chemistri test substitut immunochemistri instrument submiss parti point integr ivd segment integr clinic chemistri test immunochemistri test instrument integr express integr hia test newli introduc clinic chemistri instrument roch integra trend increas run immunochemistri test clinic chemistri instrument import note part substitut immunochemistri instrument classic chemistri instrument vice versa substitut impli clinic chemistri reagent trail gener clinic chemistri instrument reduc potenti market power supplier clinic chemistri instrument constrain supplier immunochemistri instrument indic potenti market power immunochemistri instrument constrain possibl custom switch part test clinic chemistri instrument detail instrument classif publish edma assembl sale data futur level separ segment clinic chemistri immunochemistri haematolog microbiolog add categori clinic instrument data manag system segment distinct drawn instrument size throughput instrument vari wide clinic chemistri common segment industri reflect edma classif distinguish manual instrument throughput test hour tph small autom instrument tph medium autom instrument tph larg autom instrument tph extra larg autom instrument gt tph segment relev market definit purpos distinguish manual instrument photomet autom instrument manual instrument sold doctor occasion analys offic serv demand autom instrument sold hospit privat laboratori custom demand autom instrument depend size degre flexibl choos extra larg instrument larg instrument exact prefer individu laboratori vari numer factor includ size daili throughput test peak load space personnel resourc attempt defin separ market size autom clinic chemistri instrument gener applic demand characterist individu laboratori investig parti parti suggest segment commiss consid autom clinic chemistri instrument constitut separ product market broken separ product market autom clinic chemistri instrument depend size overlap parti exist autom clinic chemistri instrument instrument type except dna probe concentr creat competit problem definit market instrument includ immunochemistri instrument left open altern market definit consid effect competit significantli imped eea substanti part area dna probe diagnost test dna probe emploi detect infecti diseas genet disord cancer cell enzymat amplif specif nucleic acid contain sampl field applic techniqu offer import advantag compar older vitro diagnost method involv biolog amplif growth cultur dna probe offer abil copi minut fragment genet materi million time order produc yield larg rapid reliabl detect infecti diseas hiv dna probe offer methodolog faster costli potenti hazard biolog amplif dna probe offer uniqu possibl quantif viral load sampl advantag effect monitor therapeut treatment patient advantag dna probe offer uniqu possibl develop diseas manag supplier roch offer diagnost test therapeut drug packag reimburs drug link perform diagnost test summari dna probe offer signific possibl end user laboratori perform test perform lower degre precis diagnost test dna probe present appli detect hiv hepat hcv mycobacterium tuberculosi mtb sexual transmit diseas std chlamydia roch introduc autom nucleic acid processor coba amplicor dna probe test manual procedur addit automatis process dna probe market undergo strong expans numer research project aim emploi dna probe area enhanc diagnost capabl carri practic technic limit dna probe techniqu requir presenc nucleic acid sampl impli area vitro diagnost futur technic reason substitut dna probe clinic chemistri abovement technolog featur uniqu abil dna probe provid diagnost result suggest insignific degre substitut dna probe diagnost method confirm price data submit parti signific price differ dna probe vitro diagnost product dna probe time expens addit data submit parti dna probe market strong phase expans roch sale commun doubl market vitro diagnost product grow slower rate commiss conclud dna probe constitut separ market relev geograph market notif parti market vitro diagnost worldwid eea statement support fact reagent instrument gener market europ ident form ident design label product produc manufactur site major competitor present worldwid basi suppli side product amp carri european worldwid scale commiss consid definit relev product market primarili base demand side consider previou decis ivd industri commiss found geograph refer market vitro diagnost concern tdm dat haematolog remain essenti nation custom switch easili supplier locat commiss investig case confirm result custom competitor contact commiss market nation provid inform support conclus reagent custom state bui product member state viabl altern custom stress import rapid reliabl servic ensur continu avail reagent instrument servic provid supplier local presenc commiss previous found signific price differ reagent member state confirm custom competitor investig price differ substanti parti price data show substanti price differ reagent member state price differ reflect divers nation medic cultur diverg nation health polici social secur regul technolog laboratori import level reimburs exist diagnost test member state price strategi ivd supplier link reimburs level higher price demand member state custom laboratori obtain higher price higher reimburs element point exist nation market reagent fact major competitor nation distribut system exist appreci differ parti market share neighbour geograph area instrument parti claim unabl provid meaning price comparison reason cite market instrument nation rapid reliabl servic import reduc machin downtim custom bui instrument local differ nation medic system lead differ size laboratori differ technolog competitor nation distribut system appreci differ parti market share neighbour geograph area reagent instrument nation regul plai role stringent case pharmaceut commiss prepar direct harmonis nation regul vitro diagnost direct adopt effect immedi period year allow implement import note harmonis effort address question product approv question reimburs approv continu determin member state independ market studi submit parti note respect compani allow sell product eu countri secur signific busi limit reimburs approv base consid product market essenti nation assess commiss conclus oper notifi form creat strengthen domin posit number nation market clinic chemistri reagent instrument oper strengthen roch domin posit dna probe classic clinic chemistri reagent instrument effect merger market share addit parti activ overlap clinic chemistri reagent ccr instrument perform test overlap rapid strip test roch activ market ccr parti combin market share amp lt eea bm amp lt roch amp lt nation basi member state constitut affect market tabl base parti submiss show market share gt tabl gt instrument statist inform ivd instrument combin basi member state affect market parti overlap instrument austria roch amp lt bm amp lt belgium roch amp lt bm amp lt denmark roch amp lt bm amp lt finland roch amp lt bm amp lt franc roch amp lt bm amp lt germani roch amp lt bm amp lt greec roch amp lt bm amp lt itali roch amp lt bm amp lt netherland roch bm amp lt norwai roch amp lt bm amp lt portug roch bm amp lt spain roch amp lt bm amp lt sweden roch amp lt bm amp lt unit kingdom ireland roch amp lt bm amp lt parti limit posit immunochemistri haematolog microbiolog market share underst parti share market clinic chemistri instrument close link sale instrument sale reagent commiss consid parti share instrument close relat reagent discrep logic parti higher market share instrument small reagent supplier sell instrument product instrument major competitor competitor reduc parti market share reagent instrument parti state notif market share instrument reagent correspond close view dade behr notif case iv commiss consid market share clinic chemistri reagent set repres parti market share clinic chemistri instrument parti contest assumpt proceed tabl bm high market share market leader member state number competitor rang intern firm presenc member state small reagent produc employe activ countri origin market share competitor vari member state member state import competitor order market share johnson amp johnson amp beckman bayer dade behr merck kgaa merck olympu eea bm market share significantli higher competitor high market share largest competitor combin individu time larg amp beckman time larg bayer dade behr merck olympu market share half size competitor roch market share smaller amp beckman bayer size merck dade behr analysi tabl reveal posit competitor geograph market import market share addit creat merger austria germani bm market share exceed market share gap largest competitor austria amp gt germani amp gt competitor challeng bm posit market germani acknowledg roch roch diagnost chemistri laboratori system intern market plan state bm domin concentr strengthen domin posit austria remov biggest competitor market germani addit market share widen gap bm competitor spain bm market share time larg largest competitor special featur market owner instrument laboratori distributor amp spain combin market share compani combin bm share bm posit market challeng competitor addit roch share widen gap portug bm market share time larg largest competitor addit roch market share amp lt increas lead remov competit impact biggest competitor market finland bm market share larg largest competitor roch combin market share close larger competitor combin sweden bm market share larg amp largest competitor roch add amp lt lead combin roch bm larg competitor combin itali bm market share larg largest competitor roch combin market share close larger competitor combin denmark situat bm market share lower averag european share roch high market share combin roch bm undisput leader market share doubl largest competitor norwai bm market share higher competitor larger roch bm combin belgium netherland franc greec unit kingdom ireland investig competit concern parti combin market share compar lower competitor market compar market posit ii addit instal base addit high market share investig merger roch bm strong advantag term greatest instal base instrument number instrument sold year instal base import import number instrument year main reason determin larg extent sale volum reagent reagent trail lifetim instrument year instal base strongli influenc futur placement instrument easier supplier place instrument current cc custom decis maker replac cc custom supplier previous relationship decis maker cc instrument decid purchas ivd instrument supplier larg instal base instrument abbott similar access cc custom custom choic instrument lock effect irrespect bought instrument receiv supplier exchang conclus reagent deliveri contract lock effect aris contractu commit econom rational oper laboratori busi custom bought instrument replac end depreci period year custom receiv instrument reagent deliveri contract roch bm typic conclud period year contractu period custom commit purchas reagent express term yearli minimum number test kit instrument supplier year standard contract submit roch forese possibl earli termin contract yearli purchas oblig calcul individu custom basi project annual consumpt custom econom incent concentr larg proport test specif instrument reduc test cost optim invest capit minimis cost train personnel total price paid custom includ rental fee instrument calcul take account initi price instrument contractu period period capit cost typic agreement includ provis addit servic train custom staff mainten suppli dispos instal base amp lt clinic chemistri instrument bm amp lt roch amp lt total instal base parti eea time larg largest competitor amp bayer instrument exce largest competitor member state tabl show total instal base parti major competitor member state addit market share competit concern gt tabl gt larg instal base number custom reinforc market posit parti respect support document submit roch notif assess bm extens instal base high volum reagent product bm obtain signific economi scale high oper margin clinic chemistri mix busi instrument reagent sale good reagent open system qualiti bm reagent permit high captur rate instrument allow bm maintain margin import note concentr combin largest instal base europ numer term compani respect activ larg complementari sens creat uniqu coverag size instrument bm tradit focu medium high throughput end market roch tradition strongest segment small instrument coba mira instrument suggest exist competitor face increas difficulti challeng roch bm strong combin posit gener focus segment market comparison bm roch instal base biggest competitor europ amp beckman bayer dade behr merck olympu show advantag merg entiti enjoi member state combin market share suggest roch bm domin posit comparison focus aspect total instal base instrument combin irrespect instrument size number indic custom base contact supplier instal base instrument size indic reagent trail gener instrument size ensur compar instrument austria bm largest total instal base roch largest combin total instal base time larg largest competitor combin bm largest instal base instrument segment except small instrument roch leader segment combin instal base significantli larger competitor combin germani bm largest total instal base roch largest combin total instal base larg competitor combin bm largest instal base instrument segment roch instal base segment larger combin instal base competitor combin except medium size segment competitor combin base exce roch bm spain bm largest instal base segment small instrument roch strong small instrument fourth larg instrument combin larg competitor combin segment medium size instrument portug finland bm largest instal base segment roch largest instal base exclus small instrument larger competitor segment sweden roch leader small instrument bm leader medium size larg instrument bayer supplier market extra larg instrument roch bm combin larg larger competitor combin segment extra larg denmark roch largest total instal base bm largest bayer combin instal base largest segment exceed competitor combin segment medium size instrument amp largest number instrument itali bm largest total instal base roch largest bm lead segment medium size instrument beckman leader roch bm exce competitor competitor combin norwai roch leader small instrument amp larg roch bm medium size larg instrument bayer larger roch bm extra larg instrument roch bm instal base larger amp bayer combin comparison show countri bm domin posit prior merger austria germani spain control major instal base posit strengthen addit roch base focu small instrument portug finland sweden denmark combin instal base bm roch larg larger competitor combin itali larg combin total largest competitor case norwai comparison instal base suggest roch bm domin posit amp bayer posit challeng market leader effect conclud reagent instrument combin roch bm instal base strengthen bm domin posit austria germani spain facilit creation domin posit portug finland sweden denmark itali iii remov roch competitor concentr remov roch competitor market austria denmark substanti reduct competit roch lead challeng bm market austria denmark market roch biggest competitor account fact recent year roch dynam competitor ivd industri independ market studi submit parti note roch compani highest growth ivd growth revenu cc europ competit import roch clinic chemistri increas success launch instrument famili roch integra histor concentr small instrument launch larg instrument instrument begun challeng bm area tradition main focu iv increas bundl possibl competit import broad product rang result possibl bundl product field ivd industri recognis roch head roch diagnost divis note respect advantag establish leadership posit broad rang diagnost disciplin firstli abil bundl product servic custom base order offer consolid solut laboratori uniqu potenti roch bm recognis head roch diagnost divis assess merit acquir competitor bm conclud combin competitor roch compani except bmd bm successfulli bundl chemistri immunochemistri assess bm supplier successfulli bundl cc immunochemistri confirm weak posit exist competitor field cc fact abbott market leader immunochemistri present activ cc roch bm uniqu competitor successfulli bundl classic chemistri immunochemistri dna probe contest commiss investig shown actual potenti competitor countervail power demand side regard contest roch bm domin posit reason exist competitor market share import competitor analys relat roch bm share note main competitor amp beckman bayer dade behr merek olympu analys competit impact competitor import note addit weak posit compani term market share instal base biggest competitor europ bayer merck steadili declin market posit commit amp ivd industri question industri observ state parti submit lead diagnost compani develop develop gener modular instrument system cover clinic chemistri immunochemistri infecti immunolog parti opinion provid strong challeng bm exist market leadership clinic chemistri parti submit addit abbott beckman dade behr bayer develop integr instrument system true develop project progress commiss find parti argument convinc term modular impli gener instrument consist modul adapt work system modul carri clinic chemistri test carri immunochemistri test modular instrument system market eea world appear system modular dade behr rxl incorpor modul heterogen immunochemistri test modul cover clinic chemistri hia market usa parti advanc argument eventu launch rxl instrument europ significantli improv dade behr market posit clinic chemistri market shown futur modular instrument system introduc beckmann bayer compani activ market clinic chemistri improv market posit supplier rule introduct modular instrument system european market futur commiss find parti demonstr develop significantli alter market characterist clinic chemistri market import larg instal base secur futur reagent sale replac instrument parti statement modular instrument system fail account fact presum custom interest system wide access forese futur evidenc custom answer commiss investig fact current instal base clinic chemistri custom significantli vari term size test menu throughput instrument final importantli parti submiss immin impact modular instrument system contradict rational roch propos acquisit bm instrument constitut threat bm posit submit parti arguabl make sens roch pai usd billion bm major strength li field clinic chemistri introduct modular instrument system fundament chang main characterist market clinic chemistri diagnost reagent instrument forese futur basi conclud countri concentr threaten creat strengthen domin posit exist competitor posit term market share instal base effect challeng leadership roch bm expect develop market modular instrument system compani significantli improv abil challeng posit roch bm ii bui power demand side segment dimens import ownership public laboratori privat laboratori volum throughput requir small laboratori larg laboratori statu hospit laboratori dedic refer laboratori doctor practic number size custom differ member state member state depend organis nation healthcar system member state concentr demand joint purchas public laboratori joint purchas nation level combin demand local region author result member state irrespect nation specif demand side dispers suppli side notif dispers demand side reflect roch bm custom base case largest custom parti account substanti amount parti sale cc reagent countri investig competit concern highest proport found roch sale finland portug bm largest custom account member state figur roch parti face power custom concentr import percentag total demand countri expect biggest custom countervail power assess confirm fact owner largest group privat laboratori eea base germani consid posit negat market power roch bm call tender increas countervail power custom larg extent submiss parti call tender plai signific role account total volum demand itali spain portug greec unit kingdom greec unit kingdom concentr creat domin posit countri call tender expect counterbal roch bm posit case limit number larg call tender issu centralis purchas organis itali larg diagnost compani particip tender issu region author portug spain period roch particip tender countri bm issu centralis author basi conclud structur factor parti market posit constrain countervail purchas power demand side iii potenti competit barrier entri market clinic chemistri diagnost high entri signific scale requir larg invest develop cost system instrument reagent estim german diagnost manufactur associ roch bm member ecu million ecu million independ market studi submit parti estim cost excess ecu million addit entrant bear cost set sale servic organis document submit parti exist signific economi scale entrant face situat potenti custom larg lock exist instrument base reluct replac instrument written height barrier entri demonstr fact entrant signific year europ olympu note prior enter market full line supplier olympu year produc instrument sold merck eppendorf parti submit abbott world wide leader immunochemistri enter clinic chemistri market abbott limit presenc classic chemistri base instrument placement earli confirm abbott plan enter market allianc japanes instrument manufactur toshiba larg extra larg instrument acquisit french instrument manufactur alcyon small instrument parti put forward argument analys relat introduct gener modular instrument system relat abbott stage abbott entri field achiev introduct modular system offer alcyon clinic chemistri instrument alcyon limit posit market clinic chemistri europ allianc toshiba aim produc clinic chemistri modul abbott plan architect system combin instrument immunochemistri instrument produc abbott introduct clinic chemistri modul foreseen year earliest abbott access custom financi mean attempt overcom high barrier entri expect challeng roch bm domin posit short medium term abbott sale small alcyon instrument immedi financi strength abbott degre increas sale instrument current level effect expect limit larg potenti modular toshiba instrument launch abbott expect reach signific market share amp gt forese futur conclud potenti competit effect constrain market behaviour roch bm merger conclus concentr classic clinic chemistri busi roch bm result creation domin posit portug finland sweden denmark itali strengthen bm pre exist domin posit austria germani spain conclus base high combin market share attain roch bm advantag term instal base unmatch product portfolio rel weak exist competitor insuffici countervail power demand side high barrier entri immunochemistri reagent instrument market immunochemistri diagnost parti combin market share eea amp lt bm amp lt roch amp lt basi affect market found countri austria combin market share amp lt bm amp lt roch amp lt norwai combin market share amp lt bm amp lt roch amp lt germani combin market share amp lt bm amp lt roch amp lt spain combin market share amp lt bm amp lt roch amp lt market import competitor notabl abbott world leader immunochemistri compar market share bm countri dade behr consider larger share roch lower share bm beckman level edma classif notifi oper lead signific overlap specif product group immunochemistri field tabl show product group base parti combin share indic competit concern exist gt tabl gt tabl show roch bm attain market share similar size discuss relat clinic chemistri segment immunochemistri field posit consolid posit market clinic chemistri market substanti competitor constrain parti market behaviour market parti share high rheumatoid autoimmun diseas standard control austria investig confirm oper creat competit concern product instrument dedic purpos abil parti exploit strength segment constrain weaker posit immunochemistri reagent instrument addit market immunochemistri diagnost remain essenti nation dade behr compar market share parti rheumatoid autoimmun diseas eea germani present signific degre austria react attempt roch bm exploit posit austria dade behr suffici product capac sale forc counter behaviour roch bm conclud roch bm face power competitor immunochemistri field competitor primarili abbott dade behr beckman significantli activ immunochemistri product mention tabl reason investig confirm concentr creat strengthen domin posit market immunochemistri diagnost dna probe market structur dna probe statist inform edma partli classif specif chapter test parti provid market share data broken member state level aggreg data provid commun show total market ecu million increas period roch sale doubl data show roch strong posit market share amp lt main field applic hiv hepat hcv mycobacterium tuberculosi mtb sexual transmit diseas std applic repres amp lt total dna probe market amp lt area hiv hcv test increas significantli year amp lt hiv amp lt hcv roch compani suppli reagent main applic offer broadest rang test compani launch test quantit measur viral load amount viru patient blood roch compani introduc autom instrument dna probe test coba amplicor instrument dna probe test perform hour custom point view instrument advantag significantli lower process time compar manual test addit advantag autom instrument reduc risk contamin sampl instrument subsequ develop compani abbot lcx organon nasba qr provid test menu wide amplicor extent dna probe test emploi level autom test vari significantli member state germani austria itali spain franc high number autom system instal member state unit kingdom ireland greec system instal explan state nation reimburs system strong impact develop vitro diagnost industri member state dna probe reach high degre automatis parti market share differ significantli report figur commun purpos present assess commiss consid roch exist market share member state order commun posit parti roch state roch strong posit market dna probe posit base roch extens patent portfolio relat main dna probe technolog polymeras chain reaction pcr techniqu develop industri standard scientif commerci applic pcr technolog acquir roch compani cetu year emploi steadili increas number commerci applic addit fundament enabl patent issu unit state roch larg number patent cover improv technolog kei enzym process specif pathogen detect method target inform cancer cell addit patent beer issu half decad novemb european patent offic epo grant roch patent kei enzym pcr technolog taq polymeras roch enzym plai extrem import role pcr techniqu decis epo significantli enhanc divis strong patent portfolio field dna amplif conclud roch retain signific patent protect pcr technolog st centuri acquisit pcr technolog roch addit success commercialis number pcr test success spread technolog research commun grant research licenc worldwid europ licenc grant research institut univers compet diagnost manufactur bm fact pcr dna probe technolog successfulli commercialis combin roch polici extens grant research licenc led situat major publish materi dna probe deal primarili pcr publish materi submit parti investig confirm opinion pcr technolog continu commerci import dna probe technolog forese futur assess confirm ivd compani commiss investig abovement research licenc give license commercialis product equip patent pcr technolog roch activ successfulli pursu limit research licenc take legal action license requir conclud compani hold research licenc pcr posit basi licenc market dna probe product counter strong posit held roch ii bm bm licenc roch pcr research field produc sold abovement kei enzym pcr technolog taq polymeras research laboratori parti state notif bm activ dna probe market pipelin product investig reveal bm prior propos transact invest substanti effort posit market bm made effort independ collabor roch bm independ activ includ programm develop acquir substanti portfolio patent relat dna probe market list submit commiss patent divid group patent develop circumv pcr technolog gener patent relat analyt specif format improv amplif process sampl prepar patent relat altern technolog pna acquir danish compani investig reveal number exampl bm interest posit independ entri dna probe market relat reagent instrument relat reagent bm conclud collabor agreement independ parti develop dna probe product bm collabor agreement relat research commerci applic collabor agreement give bm exclus right product concern final bm conduct hous work develop dna probe test inter alia hiv term instrument bm enter agreement american compani idaho technolog bm distribut dna probe instrument research laboratori bm develop hous programm product dna probe instrument parti state bm develop project termin propos transact consumm conclud bm prior propos transact initi project view posit entri dna probe market independ roch signific bm parallel independ prepar market entri invest year amp dna probe market pcr technolog confirm strength pcr technolog compar altern technolog bm absenc propos transact strong incent reach agreement roch grant licenc commercialis pcr product expand effort develop acquir compet technolog head roch diagnost divis confirm prior propos transact agreement principl reach licens bm commercialis product pcr technolog conclud merger contrast impli parti notif conclud bm prior propos transact signific pipelin project relat dna probe market enter market absenc roch propos acquisit weak posit altern technolog parti submit abbott chiron organon genprob group refer oper dna probe market suppli product differ featur eas essenti equival investig shown compani produc dna probe product equival produc roch confirm abovement market share abbott organon genprob market share dna probe market eea offer limit number test altern technolog regard industri observ inferior pcr technolog conclud compani posit challeng roch posit dna probe market evid suggest forese futur chiron compani tradit focu infecti diseas diagnost dna probe technolog call branch dna notif chiron activ dna probe market relat exclus hiv hepat hcv chiron hold signific patent right field chiron hold strong posit eea segment dna probe market activ translat total market share chiron autom test group test exclud chiron insignific player dna probe market disadvantag instrument autom oper test addit fact activ main area dna probe market mycobacterium tuberculosi mtb sexual transmit diseas std decreas abil act signific constraint roch market posit confirm consult report submit roch assess chiron branch dna technolog suit applic signal threshold expand ivd applic suit nucleic acid amplif final group test data provid parti constitut dna probe market consist diagnost paramet distinctli lower turnov main test includ roch amplicor instrument includ viral test thlv ii enteroviru genet test cancer test addit categori includ sale instrument dispos except roch abovement compani achiev sale categori parti product categori base roch pcr technolog instrument dispos make major part remain test research stage suppli larg number smaller compani research institut conclud research licenc roch conclud test commercialis roch particip state fact research dna probe roch pcr technolog underlin fact technolog industri standard fact research pcr technolog great roch particip commercialis product flow activ extent product categori due research relat natur includ calcul market share dna probe market logic includ activ roch market share roch patent right control commercialis product test includ market roch share market roch share higher estim market dynam dna probe constitut young market high growth rate determin roch domin posit sustain parti argu respect dna probe market infant stage develop market market share figur low prob assess competit situat commiss agre technolog driven market care analysi made develop market dynam assess roch market posit continu secur reason outlin contrast case commiss found high market share erod futur competit dna probe market experienc volatil market share movement chang market leadership roch acquisit pcr technolog investig reveal indic market structur chang fundament futur contrari document submit parti parti show industri player pcr technolog continu domin technolog futur market studi submit parti estim market share pcr technolog increas year year conclud market grow fast rate left infant stage signific uncertainti remain technolog industri standard commiss conclud market posit roch dna probe erod market dynam forese futur light conclud roch domin posit dna probe market member state conclud altern technolog prospect challeng pcr technolog forese futur effect propos transact prior concentr roch year studi number candid acquisit virtual major vitro diagnost compani abbott clear document submit roch strateg plan transact focus access larger sale forc maximis market pcr product creat possibl successfulli bundl sale clinic chemistri immunochemistri dna probe product bm posit europ lead supplier clinic chemistri product major supplier immunochemistri product presenc laboratori sale market organis match activ fit object assum roch direct access bm sale market network roch consolid strengthen domin posit dna probe market technic point view forese futur combin dna probe clinic chemistri test combin instrument clear roch submiss consid commerci bundl clinic chemistri immunochemistri dna probe product feasibl advantag presum acquisit bm roch adopt market strategi roch explain presenc clinic chemistri immunochemistri strong posit bm clinic chemistri lead significantli increas possibl success bundl dna probe product effect propos transact significantli consolid strengthen domin posit dna probe market final clear bm absenc propos transact enter dna probe market independ licenc roch bm interest evidenc fact dna probe market market field vitro diagnost rapidli expand bm world top player diagnost field strong incent enter market strategi stai dna probe market long term erod exist posit market bm strategi independ entri dna probe market presum reason state exist sale forc custom base abil bundl product offer potenti competitor roch european market conclud acquisit bm consolid strengthen roch domin posit dna probe market elimin potenti entrant european market custom competitor roch bm larg confirm propos transact bring result number custom competitor express fear transact increas domin posit roch dna probe market exploit roch strong posit dna probe market custom refer roch uniqu system charg custom laboratori fix percentag turnov pcr test royalti state roch access bm sale network increas bundl possibl facilit similar tactic conclus roch prior propos transact market share amp lt dna probe market eea combin weak altern dna probe technolog roch domin posit market acquisit bm strengthen posit give roch increas access market dna probe product bm exist organis possibl successfulli bundl product compani loss bm potenti competitor roch dna probe market commun serv consolid strengthen roch domin posit conclus basi commiss reach conclus propos concentr lead creation strengthen domin posit result effect competit significantli imped mean articl merger regul market clinic chemistri reagent clinic chemistri instrument austria germani finland portug spain sweden denmark itali dna probe member state eea vi undertak submit parti view remov competit concern roch offer enter commit clinic chemistri reagent instrument clinic chemistri reagent instrument roch undertak divest coba mira busi austria germani denmark finland sweden itali portug spain purchas opportun purchas coba mira busi norwai option extend geograph scope transact member state commun asset includ transact compris titl ownership coba mira instrument assign custom custom list respect suppli agreement reagent dispos respect servic agreement stock spare part servic softwar tool purchas request grant exclus licenc cover roch patent right document includ design blueprint roch manufactur coba mira instrument addit roch readi sell buyer coba mira instrument spare part need reagent favour transfer price roch undertak effort sell busi entireti singl purchas viabl competitor clinic chemistri busi independ roch satisfact condit subject approv commiss roch seek commiss consent sell busi nation basi purchas singl purchas entir busi found roch undertak effort complet divestitur period commiss decis period truste approv commiss entitl sell busi price period truste review busi continu roch ongo viabl busi measur substanti advers impact busi dna probe dna probe roch undertak give access pcr technolog vitro diagnost applic interest market particip resourc potenti license roch offer broad target licenc offer categori broad licenc option cover fundament pcr patent option cover addit full roch present patent portfolio pcr final option license addit fundament pcr patent choic addit patent roch present patent portfolio depend license roch prepar grant license licenc futur pcr patent roch addit roch offer target licenc singl paramet competitor interest specif diseas unmet medic hla cystic fibrosi roch offer licenc discriminatori term interest parti purpos ensur discriminatori treatment license roch grant license favour custom claus addit roch agre appoint truste approv commiss inform execut licenc agreement contact license review complianc principl discrimin truste report conclus commiss ensur time implement undertak roch undertak conclud bind licenc agreement license broad licenc option commiss decis present case roch undertak conclud bind agreement target licenc date order ensur roch obtain sensit busi inform activ license roch agre ensur sale volum valu license report roch expir end period cover sale figur purpos calcul payment review royalti period license report independ auditor approv commiss oblig disclos figur roch end period vii assess undertak clinic chemistri reagent instrument commit offer roch regard coba mira rang instrument import effect addit instal base merger significantli reduc increas bm market share relat concentr coba mira line instrument repres import part roch total instal base member state merger creat competit problem merger add limit number instrument bm instal base germani spain itali amp lt instrument ad austria sweden denmark amp lt instrument finland portug amp lt number compar larg instal base bm control countri roch bm increas advantag term access custom roch custom coba mira addit undertak ensur merger combin roch strength small instrument bm strength instrument segment roch strength segment base coba mira rang instrument easi competitor challeng roch bm segment market prior concentr market reagent purchas access instal base put posit effect compet market offer reagent instal base instrument coba mira open instrument purchas provid reagent instrument cost adapt immedi serv custom coba mira roch undertak sell coba mira instrument purchas enabl act immedi full rang supplier instrument reagent small instrument segment purchas offer custom replac instrument period provid instrument product contract undertak grant exclus licenc cover patent right manufactur coba mira instrument enabl purchas start produc specif instrument type reason commiss consid parti undertak resolv competit concern outlin market clinic chemistri reagent instrument dna probe undertak licens pcr technolog interest competitor ensur entri larg ivd produc market compani commiss proceed express interest obtain commerci pcr licenc incent enter high growth market ivd industri bm prior merger scope licens programm differenti broad licenc target licenc specif paramet ensur larg competitor enter market small compani interest specif diseas unmet medic interest full breadth pcr applic small compani activ amp test research licenc roch market test sell develop result roch compani commerci pcr licenc commit conclud broad licenc target licenc period ensur market entri time broad licenc supplier activ ivd industri concern roch uniqu potenti abil bundl dna probe ivd product remov undertak undertak place license similar competit posit abil offer dna probe combin ivd product result commit commiss consid abovement reinforc domin posit dna probe aris notifi merger effect remov order commiss deal request roch relat divestitur coba mira busi paragraph request relat appoint truste auditor paragraph time fashion order reduc hardship roch opposit procedur appli commiss treatment request roch provid commiss relev data demonstr independ propos truste auditor purchas case relat propos purchas roch provid suffici inform show propos parti viabl competitor clinic chemistri busi commiss week roch submiss object request requir inform submit deem approv request viii final conclus commiss conclud subject full complianc commit made roch set letter commiss januari recit propos concentr creat strengthen domin posit result effect competit significantli imped common market substanti part adopt decis articl subject full complianc commit made hoffmann la roch set recit decis concentr hoffmann la roch group acquir control corang declar compat common market function eea agreement articl hoffmann la roch accord commit submit commiss approv propos truste auditor purchas coba mira busi provid commiss relev data demonstr independ propos truste auditor purchas case relat propos purchas hoffmann la roch provid suffici inform show propos parti viabl competitor clinic chemistri busi commiss week submiss request object requir inform submit deem approv request articl decis address hoffmann la roch grenzacherstraâ ch basel brussel februari commiss karel van miert member commiss oj corrigendum oj oj oj publish version decis inform omit replac approxim figur pursuant articl merger regul eec disclosur busi secret case iv roch syntex iv bain hoechst dade behr iv bain hoechst dade behr paragraph commiss notic definit relev market purpos commun competit law oj paragraph case iv roch syntex iv bain hoechst dade behr step integr develop observ introduct homogen immunoassai clinic chemistri instrument limit impact condit competit cc discuss market definit repeat addit roch licens bm compani produc sell taq polymeras reagent pcr process research field case iv digit kienzl paragraph iv american cyanamid shell paragraph